Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Innovative Methods Manufacturing Cancer Therapeutics.                    

*Date:*                         February 26, 2009.                    

*Time:*                         1 p.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Conference Room 406, Rockville, MD 20852 Telephone Conference Call).                    

*Contact Person:*                         Joyce C. Pegues, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892-8329, 301-594-1286,                         *peguesj@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Innovations in Cancer Sample Preparation.                    

*Date:*                         March 11-12, 2009.                    

*Time:*                         8 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6116 Executive Blvd., Room 8053, Rockville, MD 20852 (Virtual Meeting).                    

*Contact Person:*                         Sherwood Githens, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8053, Bethesda, MD 20892, 301/435-1822,                         *githenss@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Anticancer Agents.                    

*Date:*                         March 12-13, 2009.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817.                    

*Contact Person:*                         Thomas M. Vollberg, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activites, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7142, Bethesda, MD 20892, 301-594-9582,                         *vollbert@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Novel Antibody Epitope Mapping Technologies.                    

*Date:*                         March 17, 2009.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).                              ( print page 5171)    

*Contact Person:*                         Wlodek Lopaczynski, MD, PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8131, Bethesda, MD 20892, 301-594-1402,                         *lopacw@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Application of Emerging Technologies for Cancer Research.                    

*Date:*                         March 19-20, 2009.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Marriott Bethesda North Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Viatcheslav A. Soldatenkov, MD, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8050A, Bethesda, MD 20892-8329, 301-451-4758, soldatenkovv@mail.nih.gov.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Antibody Array for Cancer Detection.                    

*Date:*                         March 24, 2009.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 20877.                    

*Contact Person:*                         Lalita D. Palekar, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7141, Bethesda, MD 20892-7405, 301-496-7575,                         *palekarl@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: January 22, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-1869 Filed 1-28-09; 8:45 am]

BILLING CODE 4140-01-P